Back to Search
Start Over
2 CARDIOVASCULAR DISEASE
- Source :
- MPR Monthly Prescribing Reference. October 2019, Vol. 35 Issue 9, p2, 23 p.
- Publication Year :
- 2019
-
Abstract
- 2A Angina >CADUET Pfizer Rx Calcium channel blocker (CCB) + HMG-CoA reductase inhibitor. Amlodipine (as besylate), atorvastatin (as calcium); 2.5mg/10mg, 2.5mg/20mg, 2.5mg/40mg, 5mg/10mg, 5mg/20mg, 5mg/40mg, 5mg/80mg, 10mg/10mg, 10mg/20mg, 10mg/40mg, 10mg/80mg; [...]
- Subjects :
- Merck & Company Inc.
Bayer AG
Pfizer Inc.
Novartis AG
AstraZeneca PLC
Maxzide (Medication)
Norvasc (Medication)
Care and treatment
Risk factors
Calcium channels
Riociguat
Hypertension -- Care and treatment -- Risk factors
Elbasvir
Ivabradine
Antilipemic agents
Temsirolimus
Thioridazine
Vardenafil
Angina pectoris -- Care and treatment -- Risk factors
Protease inhibitors
Pharmaceutical industry
Fosamprenavir
Everolimus
Lopinavir
Atorvastatin
Darunavir
Simeprevir
Coronary heart disease
Grazoprevir
Amlodipine
Boceprevir
Heart diseases
Cardiovascular diseases
Subjects
Details
- Language :
- English
- ISSN :
- 08830266
- Volume :
- 35
- Issue :
- 9
- Database :
- Gale General OneFile
- Journal :
- MPR Monthly Prescribing Reference
- Publication Type :
- Periodical
- Accession number :
- edsgcl.611023609